Prithvi Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-12-2024
- Paid Up Capital ₹ 0.10 M
as on 16-12-2024
- Company Age 13 Year, 27 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -43.69%
(FY 2020)
- Profit 21.26%
(FY 2020)
- Ebitda 21.26%
(FY 2020)
- Net Worth -24.84%
(FY 2020)
- Total Assets -1.16%
(FY 2020)
About Prithvi Lifesciences
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kunal Kothari and Dhaval Kothari serve as directors at the Company.
- CIN/LLPIN
U01400MH2011PTC224348
- Company No.
224348
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Prithvi Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kunal Kothari  | Director | 24-Nov-2011 | Current |
| Dhaval Kothari | Director | 05-Sep-2015 | Current |
Financial Performance of Prithvi Lifesciences.
Prithvi Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 43.69% decrease. The company also saw a substantial improvement in profitability, with a 21.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prithvi Lifesciences?
In 2016, Prithvi Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ancient Wisdom Foods And Hospitality LlpActive 8 years 3 months
Kunal Kothari and Dhaval Kothari are mutual person
- Miracle Science & Technology LlpActive 2 years 11 months
Kunal Kothari and Dhaval Kothari are mutual person
- Prithvi Natural Resources Private LimitedActive 14 years 7 months
Kunal Kothari and Dhaval Kothari are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prithvi Lifesciences?
Unlock and access historical data on people associated with Prithvi Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prithvi Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prithvi Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
